Medexus Pharmaceuticals Inc.

MEDXF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$0$1-$1$1
Dep. & Amort.$2$2$2$2
Deferred Tax-$0$0-$0$0
Stock-Based Comp.-$0$0$0$0
Change in WC-$0$1$1$1
Other Non-Cash$2$0-$0$3
Operating Cash Flow$3$4$2$7
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions-$2-$0-$2-$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$2$0-$0
Investing Cash Flow-$2-$2-$2-$0
Financing Activities
Debt Repay.-$1-$16-$3-$3
Stock Issued$0$0$19$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$1-$1-$1
Financing Cash Flow-$2-$16$15-$4
Forex Effect-$0$0$0-$0
Net Chg. in Cash$0-$15$16$1
Supplemental Information
Beg. Cash$9$24$8$7
End Cash$9$9$24$8
Free Cash Flow$3$4$2$7
Medexus Pharmaceuticals Inc. (MEDXF) Financial Statements & Key Stats | AlphaPilot